Skip to Content
Jon S Odorico, MD

Contact Dr. Odorico

E-mail:
jon@surgery.wisc.edu

Phone:
(608) 263-0388

Mail:
600 HIGHLAND AVE
BX7375 CLINICAL SCIENCE CNTR-H4
MADISON, WI 53792-3284

Jon S Odorico, MD

Professor
Section of Kidney and Pancreas Surgery
Division of Transplantation

Education

  • MD, New York University, School of Medicine, New York, NY, 1987
  • Residency, General Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, 1987-1994
  • Postdoctoral Research Fellow, Harrison Department of Surgical Research, Hospital of the University of Pennsylvania, Philadelphia, PA, 1990-1992
  • Fellow, Transplant Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, 1994-1996

Clinical Specialties

Dr. Odorico is certified by the American Board of Surgery. He specializes in pancreatic, islet cell, and multi-organ transplants.

Dr. Odorico provides a wide range of services including Kidney Transplant and Pancreas Transplant.

Research Interests

Dr. Odorico’s research focuses on stem cell biology and differentiation, developing novel stem cell-based strategies for treating diabetes, pancreas transplantation, and islet cell transplantation.

Dr. Odorico's Lab

Funding/Grants
  • Determining the Alloimmune Response to Human iPS Cell-derived Pancreatic Beta Cells
    Funding Agency: American Society of Transplant Surgeons
    Principal Investigator(s): Jon S Odorico, MD
    More Information

Active Clinical Trials
  • Islet Transplantation in Type 1 Diabetic Patients Using a Steroid-free Immunosuppression Protocol and Thiazolidinedione Insulin Sensitizers
    Principal Investigator(s): Jon S Odorico, MD
    Status: Active, not recruiting
    [ClinicalTrials.gov: NCT00214253]
    More Information

Recent Publications
  • Ectopic Ptf1a expression in murine ESCs potentiates endocrine differentiation and models pancreas development in vitro.
    Nair GG, Vincent RK, Odorico JS
    Stem Cells 2014 May; 32(5):1195-207.
    [PubMed ID: 24375815]
    More Information
  • Man with nausea and Fever.
    Sarabu N, Radke N, Odorico JS
    JAMA Surg 2014 May 1; 149(5):487-8.
    [PubMed ID: 24622967]
    More Information
  • Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients.
    Brokhof MM, Sollinger HW, Hager DR, Muth BL, Pirsch JD, Fernandez LA, Bellingham JM, Mezrich JD, Foley DP, D'Alessandro AM, Odorico JS, Mohamed MA, Vidyasagar V, Ellis TM, Kaufman DB, Djamali A
    Transplantation 2014 Mar 27; 97(6):612-7.
    [PubMed ID: 24531846, PMC ID: 4106033]
    More Information
  • Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.
    Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB, Gibson IW, Kraus E, Liapis H, Loupy A, Nickeleit V, Randhawa P, Rodriguez ER, Rush D, Smith RN, Tan CD, Wallace WD, Mengel M, Banff meeting report writing committee
    Am. J. Transplant. 2014 Feb; 14(2):272-83.
    [PubMed ID: 24472190]
    More Information
  • Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes.
    Niederhaus SV, Leverson GE, Lorentzen DF, Robillard DJ, Sollinger HW, Pirsch JD, Torrealba JR, Odorico JS
    Am. J. Transplant. 2013 Nov; 13(11):2945-55.
    [PubMed ID: 24102905]
    More Information

webmaster@surgery.wisc.edu Copyright © 2014 The Board of Regents of the University of Wisconsin System